Can dextran-based nanoparticles mitigate inflammatory lung diseases?

被引:5
作者
Prasher, Parteek [1 ]
Sharma, Mousmee [2 ]
R Wich, Peter [3 ,4 ,5 ]
Jha, Niraj Kumar [6 ]
Singh, Sachin Kumar [7 ]
Chellappan, Dinesh K. [8 ]
Dua, Kamal [9 ,10 ]
机构
[1] Univ Petr & Energy Studies, Dept Chem, Dehra Dun 248007, Uttarakhand, India
[2] Uttaranchal Univ, Dept Chem, Dehra Dun 248007, Uttarakhand, India
[3] Univ New South Wales, Sch Chem Engn, Sydney, NSW 2052, Australia
[4] Univ New South Wales, Australian Ctr NanoMed, Sydney, NSW 2052, Australia
[5] Univ New South Wales, Ctr Adv Macromol Design, Sydney, NSW 2052, Australia
[6] Sharda Univ, Sch Engn & Technol SET, Dept Biotechnol, Greater Noida 201310, UP, India
[7] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara 144411, Punjab, India
[8] Int Med Univ, Sch Pharm, Dept Life Sci, Kuala Lumpur 57000, Malaysia
[9] Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Ultimo, NSW 2007, Australia
[10] Univ Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Fac Hlth, Ultimo, NSW 2007, Australia
关键词
acetalated dextran; aerosolized formulations; dextran; dry powder inhalers; mucus permeation; nanocomposite microparticle (nCmP); pulmonary delivery; respiratory diseases; siRNA delivery; theranostics; PULMONARY SURFACTANT; DELIVERY; MICROPARTICLES; OPTIMIZATION; FORMULATION; SIRNA;
D O I
10.4155/fmc-2021-0218
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:2027 / 2031
页数:5
相关论文
共 20 条
  • [1] Specific targeting and noninvasive magnetic resonance imaging of an asthma biomarker in the lung using polyethylene glycol functionalized magnetic nanocarriers
    Al Faraj, Achraf
    Shaik, Asma Sultana
    Afzal, Sibtain
    Al-Muhsen, Saleh
    Halwani, Rabih
    [J]. CONTRAST MEDIA & MOLECULAR IMAGING, 2016, 11 (03) : 172 - 183
  • [2] MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles
    Al Faraj, Achraf
    Shaik, Asma Sultana
    Afzal, Sibtain
    Al Sayed, Baraa
    Halwani, Rabih
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 : 1491 - 1503
  • [3] Al FarajA., 2014, PLOS ONE, V9, P90829
  • [4] Distribution of effervescent inhalable nanoparticles after pulmonary delivery: an in vivo study
    Al-Hallak, M. H. D. Kamal
    Sarfraz, Muhammad K.
    Azarmi, Shirzad
    Roa, Wilson H.
    Finlay, Warren H.
    Rouleau, Claude
    Lobenberg, Raimar
    [J]. THERAPEUTIC DELIVERY, 2012, 3 (06) : 725 - 734
  • [5] Dextran-protamine coated nanostructured lipid carriers as mucuspenetrating nanoparticles for lipophilic drugs
    Beloqui, Ana
    Angeles Solinis, Maria
    des Rieux, Anne
    Preat, Veronique
    Rodriguez-Gascon, Alicia
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 468 (1-2) : 105 - 111
  • [6] Central composite rotatable design for optimization of budesonide-loaded cross-linked chitosan-dextran sulfate nanodispersion: characterization, in vitro diffusion and aerodynamic study
    Bodas, Divyanka Shrikant
    Ige, Pradum Pundlikrao
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (07) : 1193 - 1204
  • [7] A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia
    Button, Brian
    Cai, Li-Heng
    Ehre, Camille
    Kesimer, Mehmet
    Hill, David B.
    Sheehan, John K.
    Boucher, Richard C.
    Rubinstein, Michael
    [J]. SCIENCE, 2012, 337 (6097) : 937 - 941
  • [8] Hybrid pulmonary surfactant-coated nanogels mediate efficient in vivo delivery of siRNA to murine alveolar macrophages
    De Backer, Lynn
    Naessens, Thomas
    De Koker, Stefaan
    Zagato, Elisa
    Demeester, Jo
    Grooten, Johan
    De Smedt, Stefaan C.
    Raemdonck, Koen
    [J]. JOURNAL OF CONTROLLED RELEASE, 2015, 217 : 53 - 63
  • [9] De Backer L, 2013, NANOMEDICINE-UK, V8, P1625, DOI [10.2217/nnm.12.203, 10.2217/NNM.12.203]
  • [10] Dua K, 2020, Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems